Brain Health Articles

GLP-1 Medications and Longevity: Science, Mechanisms, and the Rise of Oral Forms

Glucagon-like peptide-1 (GLP-1) receptor agonists have rapidly emerged as one of the most influential pharmaceutical classes in modern metabolic medicine. Initially developed for glycemic control in type 2 diabetes, these agents now demonstrate profound effects on...

CES 2026’s newest longevity products: what just launched, what they cost, and what they’ll change

Welcome to 2026! CES (Las Vegas, January 2026) is no longer just TVs and laptops. This year’s health-and-longevity wave is loud and clear: more home biomarkers, more “physiological age” scoring, more non-invasive sensing, and more subscription services layered on top...

The 2026 Health & Longevity Stack for Adults Over 50 (Science-Backed & Practical)

Turning 50 changes the rules of health. Muscle loss accelerates, cardiovascular risk rises, sleep becomes more fragile, and cognitive resilience depends increasingly on lifestyle. The good news: modern longevity science is clear. A small set of high-confidence...

Daily Longevity Science Research Briefing

October 04, 2025 (America/Los_Angeles) Brought to you by the Longevity Academy Executive Summary The most significant signal in the last 24 hours is the publication of a human randomized controlled trial in Cell Reports Medicine demonstrating that the diabetes drug...
UA-213402459-1